Share & Key figures
Marinomed Biotech AG has been listed on the Vienna Stock Exchange since 1 February 2019. The shares are listed in the Prime Market segment and included in the ATX Prime Index.
| Share data | |
| ISIN | ATMARINOMED6 |
| Share class | No-par bearer shares |
| Nominal capital | EUR 1,474,731 (1,474,731 no-par value shares) |
| Ticker symbol | MARI |
| Issue price (IPO) on 1.2.2019 | EUR 75.00 |
| Market capitalization (at issue price) | EUR 97.4 Mio. |
For current price information please follow the link to the website of the Vienna Stock Exchange.
Coverage
Erste Bank Group AG (Vladimira Urbankova)
Intron Health (Naresh Chouhan)
FMR/Oddo Seydler (Mohamad Vaseghi)
Stifel Europe Bank AG (Marcus Wieprecht)
| Selected key financial figures | ||
| in EUR Mio. | 2019 | 2018 |
| Revenues | 6.14 | 4.67 |
| Operating result (EBIT) | -6.21 | -5.14 |
| Loss for the year | -7.22 | -12.10 |
| Adjusted annual result 1) | -4.56 | |
| Cash and cash equivalents per 31.12. | 12.02 | 1.72 |
| Balance sheet total per 31.12. | 19.50 | 5.26 |
| Net cash flow | 10.30 | -4.31 |
1) Adjusted annual result, excluding one-off special effects (valuation of the convertible bond and IPO costs)